Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Format of the Annual Disclosure to be made by an entity identified as a Large Corporate

Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Compay TORRENT PHARMACEUTICALS LTD. 2 CIN L24230GJ1972PLC002126 3 Report filed for FY 2019-20 Details of the borrowings (all figures in Rs crore) 4 Incremental borrowing done in FY(a) 750 5 Mandatory borrowing to be done through issuance of debt securities(b) = (25% of a) 188 6 Actual borrowings done through debt securities in FY(c) 300 7 Shortfall in the mandatory borrowing through debt securities, if any (d) = (b) - (c) { If the calculated value is zero or negative, write 'nil'} 0 8 Reasons for shortfall, if any, in mandatory borrowings through debt securities Not Applicable Name of the Company Secretary :-Mahesh AgrawalDesignation :-Company Secretary Name of the Chief Financial Officer :- Sudhir Menon Designation : -Chief Financial Officer Date: 31/01/2020
11-05-2020
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

In compliance with the requirements under 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Compliance Certificate for half year ended on 31st March, 2020.
06-05-2020
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Compliance Certificate Under Regulation 40(9) Of The SEBI (LODR) Regulations, 2015

With reference to the above, we send herewith a copy of the Compliance Certificate under Regulation 40(9) of the SEBI (LODR) Regulations, 2015 issued by the Practicing Company Secretary, Rajesh Parekh & Co., Ahmedabad in respect of transfer of securities of the Company during the half year ended on 31st March, 2020 Kindly find the same in order.
04-05-2020
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Shareholding for the Period Ended April 24, 2020

Torrent Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended April 24, 2020. For more details, kindly Click here
30-04-2020
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Shareholding for the Period Ended March 31, 2020

Torrent Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here
29-04-2020
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Statement Of Investor Complaints For The Quarter Ended March 2020

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Mahesh AgrawalDesignation :- Company Secretary and Compliance Officer
28-04-2020
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Issue of Securities

Intimation regarding issue of Non-Convertible Debentures on Private Placement basis
24-04-2020
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Credit Rating

Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, it is hereby informed that India Ratings and Research Private Limited has affirmed / assigned the rating on various instruments of the Company. This is for your information and record.
22-04-2020
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 11, 2020 for Torrent Pvt Ltd
11-04-2020
Next Page
Close

Let's Open Free Demat Account